These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 9563410)

  • 1. Prevalence and infectivity of hepatitis G virus and its strain variant, the GB agent, in volunteer blood donors in Taiwan.
    Wang JT; Chen PJ; Liu DP; Sheu JC; Wang TH; Chen DS
    Transfusion; 1998 Mar; 38(3):290-5. PubMed ID: 9563410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of hepatitis G virus and its strain variant, the GB agent, in blood donations and their transmission to recipients.
    Roth WK; Waschk D; Marx S; Tschauder S; Zeuzem S; Bialleck H; Weber H; Seifried E
    Transfusion; 1997 Jun; 37(6):651-6. PubMed ID: 9191828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiological and clinical aspects of hepatitis G virus infection in blood donors and immunocompromised recipients of HGV-contaminated blood.
    Heuft HG; Berg T; Schreier E; Künkel U; Tacke M; Schwella N; Hopf U; Salama A; Huhn D
    Vox Sang; 1998; 74(3):161-7. PubMed ID: 9595643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of GB virus C/hepatitis G virus-RNA and anti-envelope antibody in high-risk populations in Taiwan.
    Hwang SJ; Chu CW; Lu RH; Lan KH; Wu JC; Wang YJ; Chang FY; Lee SD
    J Gastroenterol Hepatol; 2000 Oct; 15(10):1171-5. PubMed ID: 11106098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High prevalence of GBV-C/HGV among relatives of GBV-C/HGV-positive blood donors in blood recipients and in patients with aplastic anemia.
    Seifried C; Weber M; Bialleck H; Seifried E; Schrezenmeier H; Roth WK
    Transfusion; 2004 Feb; 44(2):268-74. PubMed ID: 14962319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Status and natural course of GB virus C/hepatitis G virus infection among high-risk groups and volunteer blood donors in Taiwan.
    Yu ML; Chuang WL; Wang LY; Dai CY; Chiou SS; Sung MH; Chang CS; Chen SC; Wang CS; Chang TT; Chang WY
    J Gastroenterol Hepatol; 2000 Dec; 15(12):1404-10. PubMed ID: 11197051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of RNA and E2 antibodies in prospectively followed recipients of hepatitis G virus-infected blood.
    Sauleda S; Esteban JI; Hernandez JM; Reesink H; Castella D; Quer J; Hess G; Esteban R; Guardia J
    Transfusion; 1999 Jun; 39(6):633-8. PubMed ID: 10378844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural history of GBV-C/hepatitis G virus infection through the follow-up of GBV-C/hepatitis G virus-infected blood donors and recipients studied by RNA polymerase chain reaction and anti-E2 serology.
    Lefrère JJ; Loiseau P; Maury J; Lasserre J; Mariotti M; Ravera N; Lerable J; Lefèvre G; Morand-Joubert L; Girot R
    Blood; 1997 Nov; 90(9):3776-80. PubMed ID: 9345065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GB virus C/hepatitis G virus infection in KwaZulu Natal, South Africa.
    Sathar MA; Soni PN; Naicker S; Conradie J; Lockhat F; Gouws E
    J Med Virol; 1999 Sep; 59(1):38-44. PubMed ID: 10440806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease.
    Alter HJ; Nakatsuji Y; Melpolder J; Wages J; Wesley R; Shih JW; Kim JP
    N Engl J Med; 1997 Mar; 336(11):747-54. PubMed ID: 9052652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of GB virus C (also called hepatitis G virus) markers in Norwegian blood donors.
    Nordbø SA; Krokstad S; Winge P; Skjeldestad FE; Dalen AB
    J Clin Microbiol; 2000 Jul; 38(7):2584-90. PubMed ID: 10878048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence, persistence and liver enzyme levels of HGV RNA-positive blood donors determined by large-scale screening and transmission by blood components.
    Hitzler WE; Runkel S
    Clin Lab; 2004; 50(1-2):25-31. PubMed ID: 15000218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infection with hepatitis G virus and its strain variant, the GB agent (GBV-C), among blood donors in Japan.
    Yoshikawa A; Fukuda S; Itoh K; Kosaki N; Suzuki T; Hirakawa K; Nakao H; Inoue T; Fukuda M; Okamoto H
    Transfusion; 1997 Jun; 37(6):657-63. PubMed ID: 9191829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of hepatitis G virus infection compared with hepatitis C virus infection in patients undergoing chronic hemodialysis.
    Sheng L; Widyastuti A; Kosala H; Donck J; Vanrenterghem Y; Setijoso E; Soumillion A; Verslype C; Schelstraete R; Emonds MP; Hess G; Yap SH
    Am J Kidney Dis; 1998 Feb; 31(2):218-23. PubMed ID: 9469490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of present and past hepatitis G virus infection in a French haemodialysis centre.
    Desassis JF; Laperche S; Girault A; Kolko A; Bouchardeau F; Zins B; Poignet JL; Couroucé AM
    Nephrol Dial Transplant; 1999 Nov; 14(11):2692-7. PubMed ID: 10534514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The serological and molecular epidemiology of GB virus C/hepatitis G virus infection in a hepatitis C and B endemic area.
    Yu ML; Chuang WL; Dai CY; Lu SN; Wang JH; Huang JF; Chen SC; Lin ZY; Hsieh MY; Tsai JF; Wang LY; Chang WY
    J Infect; 2001 Jan; 42(1):61-6. PubMed ID: 11243756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of patients with hepatitis C virus with and without GB virus C/hepatitis G virus co-infection and efficacy of interferon alfa.
    Enomoto M; Nishiguchi S; Fukuda K; Kuroki T; Tanaka M; Otani S; Ogami M; Monna T
    Hepatology; 1998 May; 27(5):1388-93. PubMed ID: 9581696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-hepatitis G E2 antibody detection and its relation to serum HGV-RNA in patients with clotting disorders: high prevalence of HGV infection and spontaneous remission.
    Sheng L; Soumillion A; Peerlinck K; Verslype C; Schelstraete R; Gyselinck F; Emonds MP; Hess G; Vermylen J; Desmyter J; Yap SH
    Thromb Haemost; 1998 Apr; 79(4):752-5. PubMed ID: 9569187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of antibodies to E2-protein of GB virus-C/hepatitis G virus in patients with acute posttransfusion hepatitis.
    Hwang SJ; Lu RH; Chan CY; Chang FY; Lee SD
    J Med Virol; 1999 Jan; 57(1):85-9. PubMed ID: 9890427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of GB virus type C/hepatitis G virus RNA and anti-E2 among blood donors in Southeastern France.
    Cantaloube JF; Gallian P; Biagini P; Attoui H; Escher J; Zappitelli JP; Delord Y; de Micco P; de Lamballerie X
    Transfusion; 1999 Jan; 39(1):95-102. PubMed ID: 9920172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.